Khurem Farooq
Chief Executive Officer bij Gyroscope Therapeutics Ltd.
Profiel
Khurem Farooq is the founder of Aiolos Bio, Inc. He is currently the Chief Executive Officer & Director at Gyroscope Therapeutics Ltd.
and the Chief Executive Officer at One Bio, Inc. He is also a Director at Orbit Biomedical Ltd.
Previously, he was the Chief Executive Officer & Director at Gyroscope Therapeutics Holdings Plc from 2019 to 2022 and the Vice President-Global Product Strategy at Genentech, Inc. from 2013 to 2018.
He received his undergraduate degree from the University of Wolverhampton and his graduate degree from the University of Aston.
Actieve functies van Khurem Farooq
| Bedrijven | Functie | Begin |
|---|---|---|
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Chief Executive Officer | 11-04-2019 |
Orbit Biomedical Ltd.
 Orbit Biomedical Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, Orbit Biomedical Ltd. is a British biotechnology company that engages in research and development. Part of Novartis AG, the private company is based in Stevenage, UK. | Director/Board Member | 08-10-2019 |
One Bio, Inc.
 One Bio, Inc. BiotechnologyHealth Technology One Bio, Inc. is an American biotechnology company that was founded in 2023. The CEO is Khurem Farooq. | Chief Executive Officer | - |
Eerdere bekende functies van Khurem Farooq
| Bedrijven | Functie | Einde |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Chief Executive Officer | 17-02-2022 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-10-2018 |
Opleiding van Khurem Farooq
| University of Wolverhampton | Undergraduate Degree |
| University of Aston | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Orbit Biomedical Ltd.
Orbit Biomedical Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, Orbit Biomedical Ltd. is a British biotechnology company that engages in research and development. Part of Novartis AG, the private company is based in Stevenage, UK. | Commercial Services |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
One Bio, Inc.
One Bio, Inc. BiotechnologyHealth Technology One Bio, Inc. is an American biotechnology company that was founded in 2023. The CEO is Khurem Farooq. | Health Technology |
